← Eichor
Condition: Epithelioid Hemangioendothelioma Ehe Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Epithelioid Hemangioendothelioma Ehe

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors
Phase 1 · 1 location(s) · BridGene Biosciences Inc. · NCT06452160SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Phase 2 · 6 location(s) · Sarcoma Alliance for Research through Collaboration · NCT07104331
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.